Overview

Substance P Challenge in Healthy Participants

Status:
Completed
Trial end date:
2021-07-21
Target enrollment:
Participant gender:
Summary
The objectives of this enabling study are to characterize the wheal and flare responses over time following skin challenges with ascending concentrations of Substance P. This will be a 2-part study: Part 1 will aid in the understanding of the wheal and flare responses following Substance P. Part 2 will investigate the variability of the responses. Participants may be enrolled into Part 1 or Part 2, not both.
Phase:
N/A
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Histamine
Neurokinin A
Substance P